NFE2L2 and systemic sclerosis: An in vitro study on SSc revealed a notable down-regulation of Nrf2 appearing in SSc fibroblasts, which facilitated glutathione (GSH) decline and substantial ROS generation, followed by the activation of MAPKs pathway, the proliferation of fibroblasts as well as the formation of collagen [34].